SVR is associated with no risk reduction of HCC development in patients with HCV-related cirrhosis. A prospective, up-to 23 years, cohort follow-up study

✍ Scribed by De Lisi, S.; Crosignani, A.; Roffi, L.; Rossi, S.; Boccaccio, V.; Zermiani, P.; Maisonneuve, P.; Bruno, S.

• Book ID: 122137870
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 114 KB
• Volume: 46
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/j.dld.2014.01.078